Medicus Pharma (MDCX) announced that Carolyn Bonner, currently President of the Company, has also been appointed CFO, effective immediately. Bonner has been serving as Acting CFO since September 12, 2025, in addition to her responsibilities as President, providing continuity and leadership during the medical leave of departing CFO Jim Quinlan, who has now formally resigned for health reasons.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDCX:
- Medicus Pharma explores novel treatment innovations for prostate, skin cancers
- Medicus Pharma files to sell 2.68M common shares for holders
- Is MDCX a Buy, Before Earnings?
- Optimistic Buy Rating for Medicus Pharma Ltd Driven by Promising SkinJect Developments and Strategic Initiatives
- Medicus Pharma Seeks FDA Priority Voucher for Innovative Skin Cancer Treatment